Vicarious SurgicalRBOT
RBOT
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
126% more capital invested
Capital invested by funds: $10.5M [Q3] → $23.6M (+$13.2M) [Q4]
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
0.9% less ownership
Funds ownership: 35.14% [Q3] → 34.23% (-0.9%) [Q4]
12% less funds holding
Funds holding: 33 [Q3] → 29 (-4) [Q4]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$8.50
33%
upside
Avg. target
$8.50
33%
upside
High target
$8.50
33%
upside
1 analyst rating
0 positive
0%
1 neutral
100%
0 negative
0%
Piper Sandler Adam Maeder 57% 1-year accuracy 8 / 14 met price target | 33%upside $8.50 | Neutral Maintained | 18 Mar 2025 |
Financial journalist opinion
Based on 6 articles about RBOT published over the past 30 days
Neutral
Business Wire
1 week ago
Vicarious Surgical Announces President Transition to Board Member Role
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that Company President, Randy Clark, will transition to Board Member, effective April 25, 2025, pending customary conflict checks. As President, Mr. Clark directed critical business functions, including product development, operations, clinical regulatory, qu.
Positive
Zacks Investment Research
1 week ago
What Makes D8 (RBOT) a New Buy Stock
D8 (RBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Neutral
Seeking Alpha
2 weeks ago
Vicarious Surgical Inc. (RBOT) Q4 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Kaitlyn Brosco - Director-IR Adam Sachs - Co-Founder and CEO Randy Clark - President Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - Cowen Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Fourth Quarter and Full Year Earnings Call.
Neutral
Business Wire
2 weeks ago
Vicarious Surgical Reports Fourth Quarter and Full Year 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter and full year ended December 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, March 17, 2025. “2024 was a pivotal year of progress for Vicarious Surgical, as we expanded our strategic hosp.
Neutral
Business Wire
2 weeks ago
Vicarious Surgical Announces Appointment of Sarah Romano as Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment of Sarah Romano as Chief Financial Officer (CFO), effective April 1, 2025. Ms. Romano will oversee Vicarious Surgical's financial strategy, leveraging decades of financial leadership experience in capital markets. With exceptional strategic ac.
Neutral
Business Wire
4 weeks ago
Vicarious Surgical to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 17, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the fourth quarter and fiscal year ended December 31, 2024 after the market closes on Monday, March 17, 2025. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors inte.
Neutral
Business Wire
1 month ago
Vicarious Surgical Announces Planned Retirement of Chief Operating Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced Chief Operating Officer (COO) John Mazzola will retire, effective April 1, 2025, after nearly 40 years in healthcare manufacturing, supply chain and quality control. Mr. Mazzola will continue to serve as COO until the effective date, at which time his respons.
Neutral
Business Wire
3 months ago
Vicarious Surgical Announces Departure of Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical's CFO since January 2021. He will assist.
Neutral
Seeking Alpha
4 months ago
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical's Third Quarter 2024 Earnings Call. My name is Lydia and I'll be your operator today.
Neutral
Business Wire
4 months ago
Vicarious Surgical Reports Third Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, November 12, 2024. “Our team's strong execution throughout the year, continuing in the third quarter, has us on track to ac.
Charts implemented using Lightweight Charts™